Mail

UK markets close in 1 hour 57 minutes

FTSE 100
8,219.17
+47.02(+0.58%)
FTSE 250
20,168.88
+116.55(+0.58%)
AIM
771.35
+3.24(+0.42%)
GBP/EUR
1.1662
-0.0021(-0.18%)
GBP/USD
1.2575
+0.0042(+0.33%)
Bitcoin GBP
48,811.09
+2,205.87(+4.73%)

11 fabulous farmhouses perfect for living a rural lifestyle

A farmhouse could be your dream home if you’re in search of bucolic bliss

Portage Biotech Inc. (PRTG)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

0.2650

+0.0050

(+1.89%)

As of 09:32AM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	5.14M
Enterprise value	75.96k
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	0.16
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-0.00

Trading information

Stock price history

Beta (5Y monthly)	99.75
52-week change ³	-91.71%
S&P500 52-week change ³	22.43%
52-week high ³	4.4000
52-week low ³	0.2000
50-day moving average ³	0.4676
200-day moving average ³	1.4927

Share statistics

Avg vol (3-month) ³	97.58k
Avg vol (10-day) ³	132.14k
Shares outstanding ⁵	19.78M
Implied shares outstanding ⁶	19.78M
Float ⁸	10.21M
% held by insiders ¹	38.82%
% held by institutions ¹	11.65%
Shares short (15 Apr 2024) ⁴	8.38k
Short ratio (15 Apr 2024) ⁴	0.09
Short % of float (15 Apr 2024) ⁴	0.06%
Short % of shares outstanding (15 Apr 2024) ⁴	0.04%
Shares short (prior month 15 Mar 2024) ⁴	15.35k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	04 Jun 2020
Ex-dividend date ⁴	N/A
Last split factor ²	1:100
Last split date ³	04 Jun 2020

Financial highlights

Fiscal year

Fiscal year ends	31 Mar 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-9.13%
Return on equity (ttm)	-145.19%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-18.93M
Net income avi to common (ttm)	-144.9M
Diluted EPS (ttm)	-8.5200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	5.34M
Total cash per share (mrq)	0.27
Total debt (mrq)	275k
Total debt/equity (mrq)	0.88%
Current ratio (mrq)	2.78
Book value per share (mrq)	1.62

Cash flow statement

Operating cash flow (ttm)	-15.86M
Levered free cash flow (ttm)	-8.47M